Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.
about
Transient receptor potential (TRP) channels and cardiac fibrosisMyofibroblasts: trust your heart and let fate decide.Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivoSinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited ratsIncreased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B167: echocardiography and magnetic resonance imaging study.Echocardiographic evaluation of diastolic heart failureMyocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease.Masked hypertension associates with left ventricular hypertrophy in children with CKDCardiac fibroblast in development and wound healing.Fibrosis quantification in Hypertensive Heart Disease with LVH and Non-LVH: Findings from T1 mapping and Contrast-free Cardiac Diffusion-weighted imagingTherapeutic strategies for diastolic dysfunction: a clinical perspective.Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.Subclinical Myocardial Disease in Heart Failure Detected by CMR.Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T₁ mapping.Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function.Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionCardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary diseaseMitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene.The overexpression of Twinkle helicase ameliorates the progression of cardiac fibrosis and heart failure in pressure overload model in mice.Assessment of myocardial fibrosis with cardiovascular magnetic resonance.An updated concept for left ventricular hypertrophy risk in hypertension.Potential reduction of interstitial myocardial fibrosis with renal denervation.Regression of cardiac growth in kidney transplant recipients using anti-m-TOR drugs plus RAS blockers: a controlled longitudinal studyCCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trialMyocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertensionA Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling.Diastolic heart failure: recognition, diagnosis and management.Cardiac metabolic alterations in hypertensive obese pigsA prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial).Clinical experience with angiotensin receptor blockers with particular reference to valsartan.TGF-β Small Molecule Inhibitor SB431542 Reduces Rotator Cuff Muscle Fibrosis and Fatty Infiltration By Promoting Fibro/Adipogenic Progenitor Apoptosis.Mechanical stretch up-regulates the B-type natriuretic peptide system in human cardiac fibroblasts: a possible defense against transforming growth factor-β mediated fibrosis.
P2860
Q24625500-623E6703-24F2-4126-9FF8-D98BF9E8007BQ27692541-B04C8FD3-BB69-4909-9F97-9E1A4F12593CQ28482173-8262AAC9-1DCA-44CD-AC09-A9A6E4571F4FQ28542819-1B75C517-857B-4BF8-B092-3B914A898766Q30300980-7DB46CC6-4791-4C29-82CB-18C4173966D6Q30360139-1450D51E-3F5E-4C35-893D-30BB509C68D1Q30363544-DC96ADF6-D708-427E-8C47-DED02DA485D3Q30421950-D249651F-59CF-4238-9BA6-65BE755E2D68Q30577730-AA5D82E4-BBD4-4489-B106-F0FE3CF2D0C6Q33562242-04BA21E0-0D90-42F7-8EEE-F60ECCA7AFDFQ33639215-1EC37B45-75AF-4D69-BBEB-28F2023B312BQ33673965-5D03809B-1780-4000-BEDB-FE6641DFAF29Q33928707-3CCC32ED-E7EB-4599-97B5-1A54D34664B5Q33998649-6DC73CF3-E2FC-49F6-8079-8E13FF080A8BQ34040150-C89B9A27-74DF-441C-A7B3-2A1DAFE6F429Q34216754-18C44048-3AA5-4203-959C-6097CBE711D7Q34231421-4BBD5CC2-D320-4771-B194-F50466D6CB91Q34231611-90948A64-4487-4A76-900B-46FC1A49E2BAQ34296764-E8C65172-69E7-47D0-ADBA-46C828B3CD31Q34432633-89AB1744-6B5C-4ADC-90B5-568F72E93A00Q34477882-B0781681-2A35-4B35-94B1-2759ED17BD04Q34504710-FCC138CC-B7E5-4162-9E46-C03C1C5F6A70Q34644430-0DD4818A-FD2B-43ED-A153-7220F0960425Q34700605-E3736C7F-6581-4D3C-8987-359023F69D61Q34807853-9D60B941-CB31-4B6C-A586-D3B5CD7DCA94Q34846884-9886FA94-3F73-46CB-AA97-852A4F34B528Q34986413-D8A92BEA-6D05-4036-AD79-14D7E295962AQ35115074-B0D9DD33-D5A2-42CD-AC05-B0DADB83E544Q35154685-59DD12D6-AE9E-4618-8E26-2E1A5741C24CQ35159918-D9629A9A-A23F-4E5F-B010-A19B2823A748Q35252620-8AFED29B-6523-4B41-99B5-D8F736E97C86Q35535837-5FDCABB0-58AE-44D0-A587-8D18EC583EF0Q35584082-02163446-1B4F-4F33-ADA9-5BFA92CEDFD7Q35761216-C69833DD-899A-4584-8CD9-5EC3F2FE6DBBQ35841585-2C7C7046-0E7B-4612-BBCD-DAAC41E41C3BQ35842108-4EC0EDF8-AC3E-4472-A15B-018183C894D5Q35861592-A5D87DDC-1D2C-412C-980B-8685105E6CCBQ35861992-49187682-2170-4B10-A146-6F3967EDA2B9Q36019721-ED133469-E6B6-48D8-9C15-D3A47D8211FFQ36138885-84E735B8-2E3D-4AB4-BA82-91E996BC2095
P2860
Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Losartan-dependent regression ...... ness in hypertensive patients.
@en
Losartan-dependent regression ...... ness in hypertensive patients.
@nl
type
label
Losartan-dependent regression ...... ness in hypertensive patients.
@en
Losartan-dependent regression ...... ness in hypertensive patients.
@nl
prefLabel
Losartan-dependent regression ...... ness in hypertensive patients.
@en
Losartan-dependent regression ...... ness in hypertensive patients.
@nl
P2093
P1433
P1476
Losartan-dependent regression ...... ness in hypertensive patients.
@en
P2093
Arantxa González
Javier Díez
José L Martínez Ubago
Mariano Larman
Ramón Querejeta
P304
P356
10.1161/01.CIR.0000017264.66561.3D
P407
P50
P577
2002-05-01T00:00:00Z